genengnews.com
The voyage of a cell or gene therapy from initial hypothesis to commercial delivery is complex and challenging. It requires a broad spectrum of scientific expertise, innovative technologies, and optimized processes to ensure these advanced therapeutics make it to market. In this GEN webinar, our panelists—two industry leaders—will discuss what it takes to develop a cell or gene therapy from concept to commercialization, alongside a conversation about innovations that are likely to shape the future of advanced therapy discovery and biomanufacturing.
Watch Now
As the biologics market continues to grow and the industry focuses on identifying novel targets and mechanisms to generate more effective therapeutics, biological pipelines are evolving from standard
Watch Now
Beckman Coulter
In this webinar, we will discuss how to set up and utilize a flow cytometer for nanoparticle analyses. We will first describe how to properly set up and clean a flow cytometer for small-particle experiments. Next, we will characterize the scatter and fluorescence sensitivity of the CytoFLEX. Finally, we will demonstrate how to immunophenotype extracellular vesicles (EVs) in human blood and plasma, including a discussion of common sample preparation techniques.
Watch Now
Biocompatibility is a critical part of the regulatory approval process for most medical devices. Scientific understanding of biological risks and the tools available to assess them are evolving.
Watch Now